ABN-302

N/A

Report date: 2025/01/26 15:12:14

NME

Base Information

Drug NameABN-302

Drug Alias NameABN-302

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionProtein E6 inhibitorsProtein E7 inhibitors

TargetsProtein E6Protein E7

Therapy Area/IndicationsUterine Cervical Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbion Inc

China Registration ClassN/A

Active CompaniesAbion Inc

Inactive CompaniesN/A

Active IndicationsUterine Cervical Neoplasms

Inactive IndicationsN/A

ATC CodeN/A